Update in the epidemiology of Parkinson's disease

Purpose of reviewIn the past 18 months, several important studies on the epidemiology of Parkinson's disease have been published. In particular, large cohorts have identified sufficient incident patients with Parkinson's disease to study risk or protective factors of Parkinson's disease; one of the important recent events in the field is the publication of some of their findings. Recent findingsWe will first review findings of descriptive studies on the frequency of the disease and its geographic or temporal distribution. We will then summarize the findings of analytical studies dealing with risk or protective factors in the fields of dietary and lifestyle factors (cigarette smoking, coffee and tea drinking, uric acid, dairy products), environmental exposures (pesticides, lead, manganese, welding), hormonal factors (oophorectomy), vascular risk factors (diabetes, hypertension, cholesterol level), pharmacoepidemiology (NSAIDs, statins), and familial aggregation. SummaryEpidemiologic studies have consistently found that some exposures are inversely (e.g., cigarette smoking) or positively associated with Parkinson's disease (e.g., pesticides), while their findings are, at the present time, less consistent for other exposures (e.g., NSAIDs, vascular risk factors). Finally, recent studies have investigated new research fields (e.g., hormonal factors, uric acid, pharmacoepidemiology) and additional data need to be collected.

[1]  O. Kano,et al.  GOUT AND RISK OF PARKINSON DISEASE: A PROSPECTIVE STUDY , 2008, Neurology.

[2]  B. Ritz,et al.  Statin use and the risk of Parkinson disease , 2008, Neurology.

[3]  L. Melton,et al.  Increased risk of parkinsonism in women who underwent oophorectomy before menopause , 2008, Neurology.

[4]  Jian-Min Yuan,et al.  Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. , 2007, American journal of epidemiology.

[5]  Kun-Woo Park,et al.  Prevalence of Parkinson’s disease in Korea , 2007, Journal of Clinical Neuroscience.

[6]  J. J. Wang,et al.  Population prevalence and incidence of Parkinson’s disease in an Australian community , 2007, Internal medicine journal.

[7]  D. Maraganore,et al.  Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. , 2007, Archives of general psychiatry.

[8]  Gang Hu,et al.  Coffee and tea consumption and the risk of Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[9]  B. Ritz,et al.  Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease , 2007, Neurology.

[10]  Honglei Chen,et al.  Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease , 2007, Neurology.

[11]  D. Schaid,et al.  Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. , 2007, Archives of neurology.

[12]  A. Hofman,et al.  Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease , 2007, Neuroepidemiology.

[13]  M. Weisskopf,et al.  Plasma urate and risk of Parkinson's disease. , 2007, American journal of epidemiology.

[14]  D. Schaid,et al.  Increased risk of essential tremor in first‐degree relatives of patients with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[15]  Annette B. Santamaria,et al.  State-of-the-Science Review: Does Manganese Exposure During Welding Pose a Neurological Risk? , 2007, Journal of toxicology and environmental health. Part B, Critical reviews.

[16]  Lewis E Kazis,et al.  Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease , 2007, BMC medicine.

[17]  J. A. Cook,et al.  Heterogeneity in male to female risk for Parkinson’s disease , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  K. Marder,et al.  Pooled analysis of tobacco use and risk of Parkinson disease. , 2007, Archives of neurology.

[19]  Michael Jerrett,et al.  A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities. , 2007, Environmental research.

[20]  A. Lang,et al.  Is there seasonal variation in risk of Parkinson's disease? , 2007, Movement disorders : official journal of the Movement Disorder Society.

[21]  K. Murros,et al.  Low plasma uric acid level in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[22]  Michael J Thun,et al.  Consumption of dairy products and risk of Parkinson's disease. , 2007, American journal of epidemiology.

[23]  Anette Schrag,et al.  Estimated life expectancy of Parkinson’s patients compared with the UK population , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[24]  M. Thun,et al.  Temporal relationship between cigarette smoking and risk of Parkinson disease , 2007, Neurology.

[25]  Richard W. Murrow,et al.  Lower low‐density lipoprotein cholesterol levels are associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[26]  N. Venketasubramanian,et al.  Incidence of Parkinson's disease in Singapore. , 2007, Parkinsonism & related disorders.

[27]  C. Tanner,et al.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.

[28]  D. Thurman,et al.  How common are the “common” neurologic disorders? , 2007, Neurology.

[29]  N. Scott,et al.  Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study , 2007, Occupational and Environmental Medicine.

[30]  D. Maraganore,et al.  Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies , 2006, Movement disorders : official journal of the Movement Disorder Society.

[31]  A. Blair,et al.  Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. , 2006, American journal of epidemiology.

[32]  Albert Hofman,et al.  Serum cholesterol levels and the risk of Parkinson's disease. , 2006, American journal of epidemiology.

[33]  G. Marsh,et al.  Employment as a Welder and Parkinson Disease Among Heavy Equipment Manufacturing Workers , 2006, Journal of occupational and environmental medicine.

[34]  Kevin R. Sanft,et al.  Chemical exposures and Parkinson's disease: A population‐based case–control study , 2006, Movement disorders : official journal of the Movement Disorder Society.

[35]  K. Hemminki,et al.  Familial risks of hospitalization for Parkinson’s disease in first-degree relatives: a nationwide follow-up study from Sweden , 2006, Neurogenetics.

[36]  A. Seaton,et al.  Occupational titles as risk factors for Parkinson's disease. , 2006, Occupational medicine.

[37]  J. Gorell,et al.  Whole-Body Lifetime Occupational Lead Exposure and Risk of Parkinson’s Disease , 2006, Environmental health perspectives.

[38]  M. Hernán,et al.  Survival of Parkinson's disease patients in a large prospective cohort of male health professionals , 2006, Movement disorders : official journal of the Movement Disorder Society.

[39]  W. Kukull,et al.  Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[40]  H. Checkoway,et al.  Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk. , 2006, Parkinsonism & related disorders.